Is the price fair?
What AORT's price assumes
Artivion, Inc. trades at 105× earnings against 30.9× for the median Medical Devices name, more expensive than its own group.
105
Trailing P/E · Medical Devices median 30.9 · 3.40× the median: the market pays up for this one
- Price / sales
- 3.97
Price / sales · as of 2026-Q1
- Free cash flow yield
- 1.3%
Free cash flow yield · Medical Devices median 3.9%
- Growth the price implies
- +23%
Growth the price implies · The price pays for +23% free cash flow growth a year for a decade; revenue has grown +13% a year over the last three.
Details›
- Price / book2026-Q1
- 4.04
- EV / EBIT2026-Q1
- 53.0
- EV / sales2026-Q1
- 4.32
- Healthcare median P/E362 names
- 29.9
- Medical Devices median P/E39 names
- 30.9
- Free cash flow, trailing twelve months
- $15M
- Market capitalisation
- $1.10B
- 3-year revenue growth
- +13%
Multiples from SEC filings and end-of-day closes; implied growth from a reverse discounted cash flow. Group medians across the names Ryufin tracks.